ARCHIVES

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

This article is from The Cancer Letter archive.

Vol. 27 No. 31 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

House Members Who Voted for Veto

January 3, 1986

Komen, ACS Support Payment Off-Protocol; Dilemma for Advocates

April 16, 1999

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

Rabson, Broder Interviewed At White House; Brown Says He Is Not Interested; Sartorelli Not Contracted In Brief: Special Arman Hammer Prize Aimed At Helping Rosenberg Continue His work; DEA Not Moved

November 25, 1988

HHS Proposes Six New DRGs for Leukemia, Lymphoma

July 4, 1986